Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Synthesizing evidences for policy translation: a public health discourse on rotavirus vaccine in India.

Panda S, Das A, Samanta S.

Vaccine. 2014 Aug 11;32 Suppl 1:A162-70. doi: 10.1016/j.vaccine.2014.03.037. Review.

2.

Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.

Megiddo I, Colson AR, Nandi A, Chatterjee S, Prinja S, Khera A, Laxminarayan R.

Vaccine. 2014 Aug 11;32 Suppl 1:A151-61. doi: 10.1016/j.vaccine.2014.04.080.

3.

Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.

Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P.

Vaccine. 2012 Apr 16;30(18):2839-47. doi: 10.1016/j.vaccine.2012.02.047. Epub 2012 Mar 2.

PMID:
22387220
4.

Insights from global data for use of rotavirus vaccines in India.

Rao TS, Arora R, Khera A, Tate JE, Parashar U, Kang G; Indian Rotavirus Vaccine Working Group.

Vaccine. 2014 Aug 11;32 Suppl 1:A171-8. doi: 10.1016/j.vaccine.2014.03.029. Review.

5.

Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI.

JAMA. 1998 May 6;279(17):1371-6.

PMID:
9582045
6.

Rotavirus vaccines at the threshold of implementation in India.

Tate JE, Arora R, Kang G, Parashar UD.

Natl Med J India. 2014 Sep-Oct;27(5):245-8.

PMID:
26037421
7.

Rotavirus disease and vaccines in India: a tremendous public health opportunity.

Tate JE, Arora R, Bhan MK, Yewale V, Parashar UD, Kang G.

Vaccine. 2014 Aug 11;32 Suppl 1:vii-xii. doi: 10.1016/j.vaccine.2014.05.047. No abstract available.

8.

Rotavirus gastroenteritis in India, 2011-2013: revised estimates of disease burden and potential impact of vaccines.

John J, Sarkar R, Muliyil J, Bhandari N, Bhan MK, Kang G.

Vaccine. 2014 Aug 11;32 Suppl 1:A5-9. doi: 10.1016/j.vaccine.2014.03.004.

9.

TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.

Clark A, Jauregui B, Griffiths U, Janusz CB, BolaƱos-Sierra B, Hajjeh R, Andrus JK, Sanderson C.

Vaccine. 2013 Jul 2;31 Suppl 3:C19-29. doi: 10.1016/j.vaccine.2013.05.045.

PMID:
23777686
10.

Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account.

Suwantika AA, Tu HA, Postma MJ.

Vaccine. 2013 Jul 11;31(32):3300-7. doi: 10.1016/j.vaccine.2013.04.055. Epub 2013 May 21.

PMID:
23707163
11.

Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.

Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R.

Vaccine. 2013 Oct 1;31(42):4902-10. doi: 10.1016/j.vaccine.2013.07.014. Epub 2013 Jul 16.

PMID:
23871824
12.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

PMID:
19817600
13.

Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.

Kang HY, Kim KH, Kim JH, Kim HM, Kim J, Kim MS, El Khoury AC, Kim DS.

Asia Pac J Public Health. 2013 Mar;25(2):145-58. doi: 10.1177/1010539511416806. Epub 2012 Jan 10.

PMID:
22234827
14.

Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.

Rheingans R, Anderson JD 4th, Anderson B, Chakraborty P, Atherly D, Pindolia D.

Vaccine. 2014 Aug 11;32 Suppl 1:A140-50. doi: 10.1016/j.vaccine.2014.05.073.

15.

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.

Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096.

PMID:
22520139
16.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
17.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

PMID:
16088797
18.

Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia.

Suwantika AA, Postma MJ.

BMC Public Health. 2013 Dec 1;13:1106. doi: 10.1186/1471-2458-13-1106.

19.

Rotavirus vaccine: a cost effective control measure for India.

Kumar A, Goel MK, Jain RB, Khanna P, Vibha V.

Hum Vaccin Immunother. 2012 Apr;8(4):501-4. Review.

PMID:
23071989
20.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799

Supplemental Content

Support Center